financetom
Business
financetom
/
Business
/
Manchester United Plans 100,000-Seat Stadium as Part of Old Trafford Redevelopment
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Manchester United Plans 100,000-Seat Stadium as Part of Old Trafford Redevelopment
Mar 11, 2025 6:07 AM

08:36 AM EDT, 03/11/2025 (MT Newswires) -- Manchester United ( MANU ) said Tuesday it plans to build a 100,000-seat stadium as part of the redevelopment of the Old Trafford area.

The sports club said it expects the project to add 7.3 billion British pounds ($9.44 billion) per year to the UK economy and potentially bring in 1.8 million additional visitors annually besides possibly creating 92,000 new jobs.

Shares of Manchester United ( MANU ) were up 3.7% in recent Tuesday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Match Group Stock Is Down 6% Wednesday
Why Match Group Stock Is Down 6% Wednesday
May 8, 2024
Match Group, Inc ( MTCH ) shares fell Wednesday after the company announced financial results for the first quarter. The Details: Match Group ( MTCH ) reported earnings on Tuesday after the market close that included GAAP EPS of 44 cents, beating analysts estimates of 41 cents, per Benzinga Pro. Match Group ( MTCH ) also reported sales of $859.658...
--AstraZeneca, Merck Sue Over Cancer Drug Patent Infringement
--AstraZeneca, Merck Sue Over Cancer Drug Patent Infringement
May 8, 2024
01:47 PM EDT, 05/08/2024 (MT Newswires) -- Price: 76.90, Change: +0.58, Percent Change: +0.76 ...
Generics Player Teva Pharmaceutical Aces Late-Stage Schizophrenia Drug Study, Stock Shoots Higher
Generics Player Teva Pharmaceutical Aces Late-Stage Schizophrenia Drug Study, Stock Shoots Higher
May 8, 2024
Wednesday, Teva Pharmaceutical Industries Ltd ( TEVA ) and Medincell announced results from the efficacy portion of the Phase 3 SOLARIS trial of TEV-‘749 in adult patients with schizophrenia compared to placebo. The results demonstrated that TEV-‘749 met its primary endpoint as measured by a change in the PANSS total score from baseline after eight weeks compared to placebo. PANSS measures the symptom severity...
Hyster-Yale Materials Handling Shares Surge After Q1 Results Exceed Estimates
Hyster-Yale Materials Handling Shares Surge After Q1 Results Exceed Estimates
May 8, 2024
01:49 PM EDT, 05/08/2024 (MT Newswires) -- Hyster-Yale Materials Handling ( HY ) shares surged more than 23% in recent Wednesday trading, a day after the company reported better-than-expected Q1 results. Late Tuesday, the company reported Q1 earnings of $2.93 per diluted share, up from $1.55 a year earlier. Analysts polled by Capital IQ expected $2.14. Revenue for the quarter...
Copyright 2023-2026 - www.financetom.com All Rights Reserved